NL8303549A - Injectieoplossing en werkwijze voor het bereiden daarvan. - Google Patents

Injectieoplossing en werkwijze voor het bereiden daarvan. Download PDF

Info

Publication number
NL8303549A
NL8303549A NL8303549A NL8303549A NL8303549A NL 8303549 A NL8303549 A NL 8303549A NL 8303549 A NL8303549 A NL 8303549A NL 8303549 A NL8303549 A NL 8303549A NL 8303549 A NL8303549 A NL 8303549A
Authority
NL
Netherlands
Prior art keywords
injection solution
solution
preparing
vitamin
same
Prior art date
Application number
NL8303549A
Other languages
English (en)
Dutch (nl)
Original Assignee
Gerot Pharmazeutika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerot Pharmazeutika filed Critical Gerot Pharmazeutika
Publication of NL8303549A publication Critical patent/NL8303549A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8303549A 1982-10-27 1983-10-14 Injectieoplossing en werkwijze voor het bereiden daarvan. NL8303549A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT392982 1982-10-27
AT392982A AT376879B (de) 1982-10-27 1982-10-27 Verfahren zur herstellung einer injektionsloesung

Publications (1)

Publication Number Publication Date
NL8303549A true NL8303549A (nl) 1984-05-16

Family

ID=3557346

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8303549A NL8303549A (nl) 1982-10-27 1983-10-14 Injectieoplossing en werkwijze voor het bereiden daarvan.

Country Status (7)

Country Link
AT (1) AT376879B (de)
BE (1) BE898082A (de)
CH (1) CH657525A5 (de)
DE (1) DE3337304A1 (de)
FR (1) FR2535205B1 (de)
LU (1) LU85040A1 (de)
NL (1) NL8303549A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
US5962536A (en) * 1998-07-31 1999-10-05 Komer; Gene Injectable propofol formulations
DE102007012644A1 (de) 2007-03-16 2008-09-18 Bayer Healthcare Ag Stabilisierung von Vitamin B12
AP3814A (en) * 2010-10-29 2016-09-30 Troikaa Pharmaceuticals Ltd Nasal compositions of vitamin b12

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1053736B (de) * 1956-03-02 1959-03-26 Konink Nl Gist & Spiritusfabri Verfahren zur Erhoehung der Loeslichkeit therapeutisch wirksamer Stoffe in Wasser
DE1249453B (de) * 1963-10-14
GB1076670A (en) * 1964-11-02 1967-07-19 Chugai Pharmaceutical Co Ltd A stabilised aqueous hydroxo cobalamin solution
DE2103387C3 (de) * 1971-01-26 1982-05-06 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Verwendung des Hydrochlorids von Glukosamin zur Herstellung von pharmazeutischen Präparaten
AU485607B2 (en) * 1972-12-04 1975-04-24 Ici Australia Limited Compositions
DE2522187C2 (de) * 1975-05-17 1977-10-28 Byk Gulden Lomberg Chem Fab Verwendung von Cystein oder dessen Säureadditionssalz und Natriumdisulfit zur Stabilisierung von injizierbaren, einen pH-Wert zwischen 7 und 9 aufweisenden, Vitamin B tief 12 und nichtsteroidal Entzündungshemmer enthaltenden Arzneimitteln
JPS54151668A (en) * 1978-05-22 1979-11-29 Teijin Ltd Production of fluffed fabric
LU80432A1 (de) * 1978-10-26 1979-03-19 Hoffmann K Verfahren zum herstellen einer injektionsloesung,die mono-phenylbutazon enthaelt,und injektionsloesung,hergestellt nach diesem verfahren
JPS5675436A (en) * 1979-11-22 1981-06-22 Eisai Co Ltd Solid pharmaceutical containing cobamamide or mecobalamin
JPS5675438A (en) * 1979-11-22 1981-06-22 Senjiyu Seiyaku Kk Method for stabilizing aqueous solution of cyanocobalamin
NZ195881A (en) * 1980-12-19 1984-08-24 W Lysaght Pharmaceutical compositions containing cobalt compounds

Also Published As

Publication number Publication date
DE3337304A1 (de) 1984-05-03
LU85040A1 (de) 1984-03-22
CH657525A5 (de) 1986-09-15
FR2535205A1 (fr) 1984-05-04
BE898082A (fr) 1984-02-15
ATA392982A (de) 1984-06-15
FR2535205B1 (fr) 1987-02-06
AT376879B (de) 1985-01-10

Similar Documents

Publication Publication Date Title
RU97107611A (ru) Препараты альфа-интерферона в виде стабильного водного раствора
AU567433B2 (en) Specific drug delivery
US4942167A (en) Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
CZ104898A3 (cs) Nové tekuté stálé formulace na bázi paracetamolu a jejich příprava
JPH06199662A (ja) ジクロフェナック塩用非経腸溶液
CA2379365A1 (en) Transnasal anticonvulsive compositions and modulated process
GB2100985A (en) Compositions containing buprenorphine
EP2116241B1 (de) Pharmazeutische zusammensetzung
KR101202649B1 (ko) 소듐 디클로페낙 및 β-시클로덱스트린을 포함하는 주사용약학 조성물
NL8303549A (nl) Injectieoplossing en werkwijze voor het bereiden daarvan.
JP3720262B2 (ja) 安定化したカルベジロール注射溶液
Stark et al. Dissolution of Cystine Calculi by Pelviocaliceal Irrigation with B-Penicillamine
JP3744857B2 (ja) アルファ−２，４−ジスルホフェニル−Ｎ−ｔｅｒｔ−ブチルニトロンの新規な処方物
CA1140048A (en) Etomidate-containing compositions
AU2001260935A1 (en) Novel formulations of alpha-2,4-disulfophenyl-N-tert-butylnitrone
RU2000129666A (ru) Стабильные растворы митоксантрона
KR20200018438A (ko) 향상된 용해도의 약물-함유 제형
CA2496121A1 (en) Stable formulations of hyaluronic acid for use in the therapeutic treatment of arthropathy
JP2001163776A (ja) 安定化された液剤
US6818662B2 (en) Pharmaceutical composition
JPS62126130A (ja) 動物用医薬組成物
JPH0678241B2 (ja) ｔＰＡ医薬組成物
JP2946015B2 (ja) 安定な抗ウィルス点滴用注射剤
JPH0118051B2 (de)
US4988722A (en) Parenteral compositions

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed